The Trump administration is expected to link autism to Tylenol use during pregnancy

    The Trump administration is expected to link autism to Tylenol use during pregnancy

    Title: The Trump Administration’s Controversial Claim Linking Tylenol Use to Autism During Pregnancy The Trump administration has recently made headlines with their claim that use of acetaminophen (the active ingredient in Tylenol) during pregnancy can increase the risk of autism. This assertion, which is expected to be announced later today, contradicts scientific research that has not conclusively demonstrated a causal link between the two. White House officials are also suggesting that vitamin B, commonly used in conjunction with cancer treatment, could potentially treat autism. This announcement marks another instance of the Trump administration questioning the science behind widely-used medications and stirring up controversy. In recent years, they have targeted vaccines, abortion medications, among others, leading many to believe that their ultimate goal is to undermine the scientific establishment in order to advance a political agenda. Autism has been a particular focus for Health and Human Services Secretary Robert F. Kennedy Jr., who pledged upon taking office to swiftly identify its cause within months. He has cited various factors such as synthetic food dyes, childhood vaccines, and painkiller use as potential culprits behind the rise in autism diagnoses over the past two decades. However, it is important to note that while autism diagnoses have indeed tripled during this period, acetaminophen usage has remained relatively stable throughout. Furthermore, scientists agree that genetics play a central role in determining whether or not a child will develop autism – as evidenced by the fact that if one identical twin is on the spectrum, most of the time their sibling will be too. Despite these facts, the Trump administration’s claim has sparked widespread debate and concern among medical professionals and parents alike. While it remains to be seen what impact this announcement will have in terms of public health policy or research funding, one thing is certain: The administration’s ongoing efforts to undermine scientific consensus continue to raise serious questions about their commitment to evidence-based decision making. In conclusion, the Trump administration’s claim linking Tylenol use during pregnancy with autism raises significant concerns regarding its impact on public health policy and medical research. As a blogger, I urge readers to stay informed and critically evaluate any information they come across related to this issue – especially when it comes from sources that have demonstrated a pattern of disregarding scientific consensus for political gain.

    Source: [Original Article](https://www.npr.org/sections/shots-health-news/2025/09/22/nx-s1-5550153/trump-rfk-autism-tylenol-leucovorin-pregnancy)

    #trump

    Check out my AI projects on Hugging Face, join our community on Discord, and explore my services at GhostAI!

    Leave a Reply

    Your email address will not be published. Required fields are marked *